annual EBITDA:
-$33.99M+$50.92M(+59.97%)Summary
- As of today (July 1, 2025), CDNA annual EBITDA is -$33.99 million, with the most recent change of +$50.92 million (+59.97%) on December 31, 2024.
- During the last 3 years, CDNA annual EBITDA has fallen by -$16.15 million (-90.54%).
- CDNA annual EBITDA is now -6600.00% below its all-time high of $523.00 thousand, reached on December 31, 2014.
Performance
CDNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$3.07M+$12.13M(+79.78%)Summary
- As of today (July 1, 2025), CDNA quarterly EBITDA is -$3.07 million, with the most recent change of +$12.13 million (+79.78%) on March 31, 2025.
- Over the past year, CDNA quarterly EBITDA has increased by +$14.27 million (+82.28%).
- CDNA quarterly EBITDA is now -194.50% below its all-time high of $3.25 million, reached on December 31, 2017.
Performance
CDNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$22.95M+$14.27M(+38.33%)Summary
- As of today (July 1, 2025), CDNA TTM EBITDA is -$22.95 million, with the most recent change of +$14.27 million (+38.33%) on March 31, 2025.
- Over the past year, CDNA TTM EBITDA has increased by +$59.75 million (+72.24%).
- CDNA TTM EBITDA is now -4422.98% below its all-time high of $531.00 thousand, reached on September 30, 2014.
Performance
CDNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDNA EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +60.0% | +82.3% | +72.2% |
3 y3 years | -90.5% | +80.2% | +34.7% |
5 y5 years | -95.5% | +12.7% | -53.4% |
CDNA EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -90.5% | +60.0% | -431.6% | +87.1% | at high | +73.0% |
5 y | 5-year | -316.0% | +60.0% | -273.8% | +87.1% | -2051.4% | +73.0% |
alltime | all time | -6600.0% | +60.0% | -194.5% | +87.1% | -4423.0% | +73.0% |
CDNA EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$3.07M(-79.8%) | -$22.95M(-38.3%) |
Dec 2024 | -$33.99M(-60.0%) | -$15.21M(+171.4%) | -$37.22M(-11.0%) |
Sep 2024 | - | -$5.60M(-704.4%) | -$41.83M(-30.3%) |
Jun 2024 | - | $927.00K(-105.3%) | -$59.98M(-27.5%) |
Mar 2024 | - | -$17.34M(-12.5%) | -$82.70M(-2.6%) |
Dec 2023 | -$84.92M(+38.7%) | -$19.81M(-16.6%) | -$84.92M(+6.5%) |
Sep 2023 | - | -$23.75M(+9.0%) | -$79.73M(+15.6%) |
Jun 2023 | - | -$21.80M(+11.4%) | -$68.99M(+5.7%) |
Mar 2023 | - | -$19.56M(+33.8%) | -$65.27M(+6.6%) |
Dec 2022 | -$61.22M(+243.2%) | -$14.62M(+12.3%) | -$61.22M(+4.5%) |
Sep 2022 | - | -$13.02M(-28.0%) | -$58.60M(+14.2%) |
Jun 2022 | - | -$18.07M(+16.4%) | -$51.30M(+46.0%) |
Mar 2022 | - | -$15.52M(+29.3%) | -$35.13M(+96.9%) |
Dec 2021 | -$17.84M(+118.3%) | -$12.00M(+110.3%) | -$17.84M(+182.7%) |
Sep 2021 | - | -$5.71M(+200.2%) | -$6.31M(+491.4%) |
Jun 2021 | - | -$1.90M(-207.5%) | -$1.07M(-63.0%) |
Mar 2021 | - | $1.77M(-475.6%) | -$2.88M(-64.7%) |
Dec 2020 | -$8.17M(-53.0%) | -$471.00K(+1.5%) | -$8.17M(-26.2%) |
Sep 2020 | - | -$464.00K(-87.5%) | -$11.07M(-26.0%) |
Jun 2020 | - | -$3.72M(+5.6%) | -$14.96M(-12.2%) |
Mar 2020 | - | -$3.52M(+4.5%) | -$17.05M(-2.0%) |
Dec 2019 | -$17.39M(+53.0%) | -$3.37M(-22.7%) | -$17.39M(+6.8%) |
Sep 2019 | - | -$4.36M(-24.8%) | -$16.27M(+19.5%) |
Jun 2019 | - | -$5.80M(+50.0%) | -$13.62M(+21.9%) |
Mar 2019 | - | -$3.86M(+71.2%) | -$11.17M(-1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | -$11.36M(-22.2%) | -$2.26M(+32.3%) | -$11.36M(+94.1%) |
Sep 2018 | - | -$1.71M(-49.1%) | -$5.85M(-63.4%) |
Jun 2018 | - | -$3.35M(-17.3%) | -$16.01M(+10.5%) |
Mar 2018 | - | -$4.05M(-224.6%) | -$14.49M(-0.8%) |
Dec 2017 | -$14.61M(-33.1%) | $3.25M(-127.4%) | -$14.61M(-20.3%) |
Sep 2017 | - | -$11.86M(+547.1%) | -$18.32M(+102.6%) |
Jun 2017 | - | -$1.83M(-56.0%) | -$9.04M(-46.1%) |
Mar 2017 | - | -$4.17M(+810.0%) | -$16.78M(-23.2%) |
Dec 2016 | -$21.85M(+94.0%) | -$458.00K(-82.3%) | -$21.84M(-14.7%) |
Sep 2016 | - | -$2.58M(-73.0%) | -$25.60M(-1.7%) |
Jun 2016 | - | -$9.57M(+3.8%) | -$26.04M(+35.6%) |
Mar 2016 | - | -$9.22M(+118.3%) | -$19.21M(+70.5%) |
Dec 2015 | -$11.26M(-2253.3%) | -$4.23M(+39.9%) | -$11.26M(+75.6%) |
Sep 2015 | - | -$3.02M(+10.4%) | -$6.41M(+104.0%) |
Jun 2015 | - | -$2.74M(+113.8%) | -$3.14M(+394.2%) |
Mar 2015 | - | -$1.28M(-305.1%) | -$636.00K(-221.6%) |
Dec 2014 | $523.00K(-369.6%) | $624.00K(+150.6%) | $523.00K(-1.5%) |
Sep 2014 | - | $249.00K(-208.7%) | $531.00K(+608.0%) |
Jun 2014 | - | -$229.00K(+89.3%) | $75.00K(-64.6%) |
Mar 2014 | - | -$121.00K(-119.1%) | $212.00K(-209.3%) |
Dec 2013 | -$194.00K(-84.7%) | $632.00K(-405.3%) | -$194.00K(-76.5%) |
Sep 2013 | - | -$207.00K(+125.0%) | -$826.00K(+33.4%) |
Jun 2013 | - | -$92.00K(-82.5%) | -$619.00K(+17.5%) |
Mar 2013 | - | -$527.00K | -$527.00K |
Dec 2012 | -$1.27M | - | - |
FAQ
- What is CareDx annual EBITDA?
- What is the all time high annual EBITDA for CareDx?
- What is CareDx annual EBITDA year-on-year change?
- What is CareDx quarterly EBITDA?
- What is the all time high quarterly EBITDA for CareDx?
- What is CareDx quarterly EBITDA year-on-year change?
- What is CareDx TTM EBITDA?
- What is the all time high TTM EBITDA for CareDx?
- What is CareDx TTM EBITDA year-on-year change?
What is CareDx annual EBITDA?
The current annual EBITDA of CDNA is -$33.99M
What is the all time high annual EBITDA for CareDx?
CareDx all-time high annual EBITDA is $523.00K
What is CareDx annual EBITDA year-on-year change?
Over the past year, CDNA annual EBITDA has changed by +$50.92M (+59.97%)
What is CareDx quarterly EBITDA?
The current quarterly EBITDA of CDNA is -$3.07M
What is the all time high quarterly EBITDA for CareDx?
CareDx all-time high quarterly EBITDA is $3.25M
What is CareDx quarterly EBITDA year-on-year change?
Over the past year, CDNA quarterly EBITDA has changed by +$14.27M (+82.28%)
What is CareDx TTM EBITDA?
The current TTM EBITDA of CDNA is -$22.95M
What is the all time high TTM EBITDA for CareDx?
CareDx all-time high TTM EBITDA is $531.00K
What is CareDx TTM EBITDA year-on-year change?
Over the past year, CDNA TTM EBITDA has changed by +$59.75M (+72.24%)